Design Verification Versus Validation After a Material Change
A team is designing a battery-powered surgical stapler. Design inputs include delivering 60 staples without a jam, compatibility with sterilization, and surviving a 1 m drop. Bench verification on 12 prototypes passes all tests. A design review is scheduled. The regulatory lead says validation is "just the clinical trial later." A supplier change moved an internal gear from metal to glass-filled polymer to cut cost; the change was not added to the design FMEA. Field complaints from a similar legacy device include jams after about 40 staples when lubricant dries out. The launch date is fixed, and the commercial team wants to skip additional testing.
1. Distinguish verification and validation in this case and identify the gaps in the current test program.
Read the worked answer
Verification answers whether design outputs meet design inputs: bench tests, dimensional checks, sterilization-cycle testing, and drop tests against the stated requirements. Validation answers whether the device meets user needs and intended use under actual conditions: simulated use, worst-case handling, reprocessing, and clinically relevant jam scenarios.
The current program has gaps:
- Twelve prototypes passing bench tests is verification evidence, not validation evidence.
- The gear material change was not analyzed in the design FMEA; glass-filled polymer may have different wear, lubrication sensitivity, and sterilization aging.
- The legacy jam-after-40-staples complaint is a known failure mode and should drive worst-case testing, including lubricant dry-out and extended sterilization cycles.
- The 1 m drop and 60-staple requirement should be tested at worst-case conditions, not only nominal bench conditions.
Saying validation is "just the clinical trial later" defers user-need evidence and ignores design-transfer risk.
2. What risk and design-control actions should the review require before release?
Read the worked answer
The review should require:
- Update the design FMEA with the gear material change, scoring severity, occurrence, and detection with evidence. Include wear, lubrication dry-out, sterilization aging, and jam-after-40-staples as failure modes.
- Verification at worst case: 60-staple runs after sterilization cycling, drop testing, and dry-lubricant conditions, with sample sizes justified by risk.
- Validation with representative users in simulated use, including the legacy failure scenario.
- Change control: supplier change approval, material qualification, and traceability to design inputs.
- Design transfer: ensure manufacturing and inspection controls reflect the new gear and the validation findings.
- Residual risk acceptance documented against the risk-management file.
A material substitution made for cost without FMEA and validation is a design-change escape. The review should not accept bench-only evidence for a change that affects wear and jamming.
3. The commercial team says the launch date is fixed and asks to skip additional testing. How should the quality engineer respond?
Read the worked answer
Respond with a documented risk-based position, not a schedule argument.
- The gear change affects a known field failure mode (jams after about 40 staples). Bench verification does not cover lubricant dry-out, sterilization aging, or user handling.
- Skipping testing transfers an unquantified risk to patients and the field. A launch delay is bounded; a field correction or regulatory action is not.
- Offer a phased path: release only after the minimum worst-case verification and validation on the changed gear, with the remaining non-critical testing completed post-launch under an approved plan. If the risk cannot be bounded, the launch must wait.
- Escalate through the design-review board and risk-management process. Record the decision and the residual-risk acceptance, including who accepted it.
The judgment is that schedule pressure does not convert unverified design changes into acceptable risk. The quality engineer's role is to make the risk visible and force an explicit, documented decision.